L

Luye Pharma Group
2186

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$14.75B
EV
HK$20.51B
Shares Outstanding
3.76B
Beta
0.80

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
HK$2.35
P/E 2025E
23.75x
P/Revenue 2025E
2.08x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Luye Pharma Group Ltd.

gainify

L

Luye Pharma Group Ltd.

2186

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian cancer and carcinoma of ovary; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovar...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Liu, Dian Bo

Employees

5,150

IPO Date

2014-07-09

Headquarters

No. 15 Chuang Ye Road, High-tech Industrial Development Zone, Yantai, Shandong Province, 264003, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.